| Dec 31,
2024 |
|---|
| Net income | 319 |
|---|
| Depreciation, depletion and amortization | 1,464 |
|---|
| Cash surrender value increase in excess of premiums paid | 17 |
|---|
| Asset Impairment Charges, Excluding Goodwill | 24 |
|---|
| Share-based compensation expense | 206 |
|---|
| Deferred income tax (benefit) expense | -137 |
|---|
| Pension Funding More (Less) Than Cost | -55 |
|---|
| Other | 28 |
|---|
| Accounts receivable | 144 |
|---|
| Inventories | -62 |
|---|
| Other assets | 31 |
|---|
| Accounts payable | -273 |
|---|
| Income taxes | -5 |
|---|
| Accrued liabilities and other | 42 |
|---|
| Net cash provided by operating activities | 1,483 |
|---|
| Capital expenditures | 1,466 |
|---|
| Cash paid for purchase of businesses, net of cash acquired | 719 |
|---|
| Proceeds from Life Insurance Policy | 5 |
|---|
| Proceeds from sale of property, plant and equipment | 61 |
|---|
| Deferred consideration paid | 1 |
|---|
| Other | -6 |
|---|
| Net cash used for investing activities | -2,114 |
|---|
| Additions to debt | 5,707 |
|---|
| Repayments of debt | 4,321 |
|---|
| Debt issuance costs | 63 |
|---|
| Changes in commercial paper, net | 1 |
|---|
| Other debt additions (repayments), net | 2 |
|---|
| Repayments of finance lease liabilities | 22 |
|---|
| Tax paid in connection with shares withheld from employees | 26 |
|---|
| Purchases of treasury stock | 27 |
|---|
| Cash dividends paid to shareholders | 650 |
|---|
| Other | 6 |
|---|
| Net cash provided by (used for) financing activities | 607 |
|---|
| Effect of exchange rate changes on cash and cash equivalents | -121 |
|---|
| (Decrease) Increase in cash and cash equivalents | -145 |
|---|